CD101 and Candidemia: Therefore, a new dichotomous category was created that grouped all healthy subjects, including those with normal hepatic function from Study CD101.IV.1.15, together, and all patients with candidemia and/or invasive candidiasis together with subjects with impaired hepatic function from Study CD101.IV.1.15.